Kelly Elise Dooley

Associate Professor

20022019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2002 2019

Filter
Chapter
2017

Bedaquiline

Tornheim, J. & Dooley, K. E., Jan 1 2017, Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. CRC Press, p. 2542-2549 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

bedaquiline
Multidrug-Resistant Tuberculosis
Mortality
Isoniazid
Rifampin

Management of tuberculosis in special populations

Salazar-Austin, N., Jain, S. & Dooley, K. E., Mar 30 2017, Handbook of Tuberculosis. Springer International Publishing, p. 141-190 50 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Tuberculosis
2011

Activities of rifampin, rifapentine and clarithromycin alone and in combination against Mycobacterium ulcerans disease in mice

Almeida, D., Converse, P. J., Ahmad, Z., Dooley, K. E., Nuermberger, E. & Grosset, J. H., 2011, PLoS Neglected Tropical Diseases. 1 ed. Vol. 5. e933

Research output: Chapter in Book/Report/Conference proceedingChapter

rifapentine
Mycobacterium ulcerans
Clarithromycin
Rifampin
Streptomycin

The rifamycins: Renewed interest in an old drug class

Burman, W., Dooley, K. E. & Nuermberger, E., Sep 7 2011, Antituberculosis Chemotherapy. S. Karger AG, Vol. 10. p. 18-24 7 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

rifapentine
Rifamycins
Rifampin
Pharmaceutical Preparations
Tuberculosis